Encore Tablets recalled by FDA, Bodee LLC

News
Article

FDA, Bodee LLC issue nationwide recall of Encore Tablets

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
Related Content
FDA Approves Cyclobenzaprine Sublingual Tablets for Treatment of Fibromyalgia

FDA Approves Cyclobenzaprine Sublingual Tablets for Treatment of Fibromyalgia

Ashley Gallagher
August 19th 2025
Article
Looking to the Future of Independent Pharmacy

Looking to the Future of Independent Pharmacy

Miranda Hester
August 19th 2025
Podcast
FDA Approves Fremanezumab as First Anti-CGRP Drug for Prevention of Pediatric Episodic Migraine

FDA Approves Fremanezumab as First Anti-CGRP Drug for Prevention of Pediatric Episodic Migraine

Ashley Gallagher
August 19th 2025
Article
Podcast: Pharmacy Financing With First Financial Bank

Podcast: Pharmacy Financing With First Financial Bank

August 19th 2025
Podcast
FDA Approves Concizumab as Daily Prophylaxis for Hemophilia A and B

FDA Approves Concizumab as Daily Prophylaxis for Hemophilia A and B

Ashley Gallagher
August 19th 2025
Article
FDA Approves Finerenone for Heart Failure With Left Ventricular Ejection Fraction

FDA Approves Finerenone for Heart Failure With Left Ventricular Ejection Fraction

Ashley Gallagher
August 19th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.